지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
The purpose of this study was to investigate the efficacy of clozapine in the treatment of treatment-resistant schizophrenic patients.
This multicenter open study included 77 patients drawn from 3 hospitals in Taegu. After a wash-out period of 7 days, subjects were treated with clozapine according to a standardized titration and dosage schedule for 12 weeks and evaluated at 4 points ; at baseline, and 4, 8, and 12 weeks of treatment. Patients who tolerated and responded to treatment were maintained on a regimen(100-600㎎/day) of clozapine. The psychiatric severity and functioning status of the patients were assessed by PANSS, CGI, and GAF scale.
The mean dally dosage of clozapine was 333.57±127.0㎎. All rating scores on the end point(N=70) demonstrated a significant improvement compared with baseline. Significant improvements in both PANSS positive and negative subscale scores was as early as week 4 through week 12.
The tolerability of clozapine was generally found to be good. Hypersalivation(90.0%), sedation(66.7%), and constipation(61%) were the most common adverse effects.
Our results suggest that clozapine is an effective antipsychotic drug for the treatment-resistant schizophrenics, who are non-responsive to classical antipsychotic drugs.
This multicenter open study included 77 patients drawn from 3 hospitals in Taegu. After a wash-out period of 7 days, subjects were treated with clozapine according to a standardized titration and dosage schedule for 12 weeks and evaluated at 4 points ; at baseline, and 4, 8, and 12 weeks of treatment. Patients who tolerated and responded to treatment were maintained on a regimen(100-600㎎/day) of clozapine. The psychiatric severity and functioning status of the patients were assessed by PANSS, CGI, and GAF scale.
The mean dally dosage of clozapine was 333.57±127.0㎎. All rating scores on the end point(N=70) demonstrated a significant improvement compared with baseline. Significant improvements in both PANSS positive and negative subscale scores was as early as week 4 through week 12.
The tolerability of clozapine was generally found to be good. Hypersalivation(90.0%), sedation(66.7%), and constipation(61%) were the most common adverse effects.
Our results suggest that clozapine is an effective antipsychotic drug for the treatment-resistant schizophrenics, who are non-responsive to classical antipsychotic drugs.
목차
영어 초록
서론
연구대상 및 방법
결과
고찰
결론
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
치료저항성 소아기 발병 정신분열증의 Clozapine 장기치험 1례
소아청소년정신의학
1998 .06
-
Clozapine; 약물학적 특성과 치료적 사용에 관한 고찰
생물치료정신의학
1995 .06
-
림프구에 대한 Clozapine의 생체내 유전독성
생물치료정신의학
1997 .06
-
클로자핀 반응의 임상적 예측인자 ; 치료 저항성 정신분열증 환자군 중 반응군과 비반응군간의 차이
생물치료정신의학
1998 .06
-
난치성 정신분열증환자의 Clozapine 장기치료 경험
생물치료정신의학
1995 .12
-
Suppressive Effect of Clozapine through Regulation of Chemokine (C-C motif) Ligand Genes in SH-SY5Y Human Neuroblastoma Cells
스트레스硏究
2010 .09
-
불응성 정신분열증환자의 Clozapine 치료효과
생물정신의학
1995 .01
-
Clozapine에 의한 백혈구 및 호산구 증다증 1례
생물치료정신의학
1997 .12
-
Combined Clozapine and Electroconvulsive Therapy in a Japanese Schizophrenia Patient: A Case Report
Clinical Psychopharmacology and Neuroscience
2014 .01
-
Efficacy of Asenapine in Schizophrenia Resistant to Clozapine Combined with Electroconvulsive Therapy: A Case Report
Clinical Psychopharmacology and Neuroscience
2019 .01
-
Clozapine과 연관된 확장성 심근병증
신경정신의학
2005 .01
-
정신분열병 환자에서 Clozapine치료로 유발된 강박증의 치료
생물정신의학
2005 .01
-
정신분열병에서 이세대 항정신병약물의 효과
생물치료정신의학
2004 .06
-
Efficacy of Longterm Treatment with Clozapine in Refractory Chronic Schizophrenia
대한임상약리학회 학술대회
1994 .01
-
Clozapine에 의한 야뇨증 1례
생물치료정신의학
1996 .12
-
만성 정신분열증 환자의 인지기능에 미치는 Clozapine 장기치료의 효과
생물정신의학
1994 .01
-
Clozapine Induces Apoptosis in HIT-T15 Pancreatic β-Cell Lines
생물치료정신의학
2003 .12
-
정신분열병 및 기타 정신증적 장애로 일 종합병원에 입원한 환자의 치료에서 Clozapine의 사용의 실태 : 유효성 및 부작용
생물치료정신의학
2003 .06
-
Clozapine이 혈당대사에 미치는 영향
생물치료정신의학
2000 .06
-
Successful Early Clozapine Trial in the Treatment of First-episode Schizophrenia: A Case Report
Clinical Psychopharmacology and Neuroscience
2013 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
양극성장애와 조현병 환자의 분노대응 방식 비교
권민정
,
문은수
,
박제민
외 4명
생물치료정신의학
2012
.12
정신분열증 환자 치료에서 Risperidone과 Haloperidol의 사용시 치료 비용 비교
이태진
,
김도훈
생물치료정신의학
2002
.12
만성정신분열증 환자에 대한 리스페리돈 장기투여 2례
박순원
,
강병조
생물치료정신의학
1995
.12
북미지역 알코올중독 치료 프로그램 분석 : 재발방지를 중심으로
김성재
한국간호교육학회지
1999
.12
치료감호중인 조현병 환자에서 정신병질적 성격평가 : 한국판 정신병질성격평가 검사 개정판을 이용하여
권지현
,
이미지
,
이재우
외 2명
생물치료정신의학
2012
.12
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-513-017205597